Novo Nordisk says Alzheimer's drug trial fails, hammering shares – Reuters

Written by

admin

in

  1. Novo Nordisk says Alzheimer’s drug trial fails, hammering shares  Reuters
  2. Novo Nordisk shares plunge 9% after Alzheimer’s drug trial fails to hit key target  CNBC
  3. Novo Nordisk’s semaglutide fails to slow Alzheimer’s progression  statnews.com
  4. Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1  Seeking Alpha
  5. Stock Market Today: Futures Tip Up to Start Week; Novo Nordisk Plummets After Ozempic Alzheimer’s Miss  TheStreet

Continue Reading

More posts